SAN JOSE, Costa Rica, May 22, 2025--Logistic Properties of the Americas (NYSE American: LPA) ("LPA" or the "Company") announced today a strategic partnership with EPICO, a Costa Rica-based firm ...

Institutional and individual investors agree to specific investment terms presented in a limited partnership agreement (LPA). What separates each classification of partners in this agreement is ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...